225 related articles for article (PubMed ID: 20575467)
1. Evaluation of two immunoassays for the measurement of human chorionic gonadotropin in urine for anti-doping purposes.
Robinson N; Sottas PE; Saugy M
Clin Lab; 2010; 56(5-6):197-206. PubMed ID: 20575467
[TBL] [Abstract][Full Text] [Related]
2. Performance characteristics of two immunoassays for the measurement of urinary luteinizing hormone.
Robinson N; Saudan C; Sottas PE; Mangin P; Saugy M
J Pharm Biomed Anal; 2007 Jan; 43(1):270-6. PubMed ID: 16884883
[TBL] [Abstract][Full Text] [Related]
3. Analytic evaluation of the beta-human chorionic gonadotropin assay on the Abbott IMx and Elecsys2010 for its use in doping control.
Shahzad K; Kim DH; Kang MJ
Clin Biochem; 2007 Nov; 40(16-17):1259-65. PubMed ID: 17884034
[TBL] [Abstract][Full Text] [Related]
4. Quantification of urinary chorionic gonadotropin in spontaneous abortion of pre-clinically recognized pregnancy: method development and analytical validation.
Reis MF; Aniceto P; Aguiar P; Simão F; Segurado S
Int J Hyg Environ Health; 2007 May; 210(3-4):419-27. PubMed ID: 17336148
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of immunoassays for the measurement of erythropoietin (EPO) as an indirect biomarker of recombinant human EPO misuse in sport.
Abellan R; Ventura R; Pichini S; Remacha AF; Pascual JA; Pacifici R; Di Giovannandrea R; Zuccaro P; Segura J
J Pharm Biomed Anal; 2004 Sep; 35(5):1169-77. PubMed ID: 15336362
[TBL] [Abstract][Full Text] [Related]
6. Effects of recombinant human LH and hCG on serum and urine LH and androgens in men.
Handelsman DJ; Goebel C; Idan A; Jimenez M; Trout G; Kazlauskas R
Clin Endocrinol (Oxf); 2009 Sep; 71(3):417-28. PubMed ID: 19170708
[TBL] [Abstract][Full Text] [Related]
7. Urinary screening tests for fetal Down syndrome: II. Hyperglycosylated hCG.
Cole LA; Shahabi S; Oz UA; Rinne KM; Omrani A; Bahado-Singh RO; Mahoney MJ
Prenat Diagn; 1999 Apr; 19(4):351-9. PubMed ID: 10327141
[TBL] [Abstract][Full Text] [Related]
8. Immunoassays for the measurement of IGF-II, IGFBP-2 and -3, and ICTP as indirect biomarkers of recombinant human growth hormone misuse in sport. Values in selected population of athletes.
Abellan R; Ventura R; Palmi I; di Carlo S; Bacosi A; Bellver M; Olive R; Pascual JA; Pacifici R; Segura J; Zuccaro P; Pichini S
J Pharm Biomed Anal; 2008 Nov; 48(3):844-52. PubMed ID: 18617352
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of immunoassays for the measurement of insulin and C-peptide as indirect biomarkers of insulin misuse in sport: values in selected population of athletes.
Abellan R; Ventura R; Palmi I; di Carlo S; di Giovannandrea R; Bellver M; Olive R; Pascual JA; Pacifici R; Segura J; Zuccaro P; Pichini S
J Pharm Biomed Anal; 2009 Apr; 49(3):793-9. PubMed ID: 19181472
[TBL] [Abstract][Full Text] [Related]
10. Influence of multiple injections of human chorionic gonadotropin (hCG) on urine and serum endogenous steroids concentrations.
Strahm E; Marques-Vidal P; Pralong F; Dvorak J; Saugy M; Baume N
Forensic Sci Int; 2011 Dec; 213(1-3):62-72. PubMed ID: 21798680
[TBL] [Abstract][Full Text] [Related]
11. Urinary human chorionic gonadotropin isoform concentrations in doping control samples.
Butch AW; Woldemariam GA
Drug Test Anal; 2016 Nov; 8(11-12):1147-1151. PubMed ID: 27594536
[TBL] [Abstract][Full Text] [Related]
12. Comparison of newly developed immuno-MS method with existing DELFIA(®) immunoassay for human chorionic gonadotropin determination in doping analysis.
Lund H; Snilsberg AH; Halvorsen TG; Hemmersbach P; Reubsaet L
Bioanalysis; 2013 Mar; 5(5):623-30. PubMed ID: 23425277
[TBL] [Abstract][Full Text] [Related]
13. Loss of human chorionic gonadotropin in urine during storage at -20°C.
Lempiäinen A; Hotakainen K; Alfthan H; Stenman UH
Clin Chim Acta; 2012 Jan; 413(1-2):232-6. PubMed ID: 21988940
[TBL] [Abstract][Full Text] [Related]
14. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
Spencer K
Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030
[TBL] [Abstract][Full Text] [Related]
15. Stability of immunoreactive beta-core fragment of hCG.
de Medeiros SF; Amato F; Norman RJ
Obstet Gynecol; 1991 Jan; 77(1):53-9. PubMed ID: 1984227
[TBL] [Abstract][Full Text] [Related]
16. Validation of the human chorionic gonadotropin immunoassay in cerebrospinal fluid for the diagnostic work-up of neurohypophyseal germinomas.
González-Sánchez V; Moreno-Pérez O; Pellicer PS; Sánchez-Ortiga R; Guerra RA; Dot MM; Alfonso AM
Ann Clin Biochem; 2011 Sep; 48(Pt 5):433-7. PubMed ID: 21719508
[TBL] [Abstract][Full Text] [Related]
17. Analysis of human chorionic gonadotropin (hCG): application of routine immunological methods for initial testing and confirmation analysis in doping control.
Kuuranne T; Ahola L; Pussinen C; Leinonen A
Drug Test Anal; 2013 Aug; 5(8):614-8. PubMed ID: 23303576
[TBL] [Abstract][Full Text] [Related]
18. Detection of human chorionic gonadotrophin misuse in sports.
Delbeke FT; Van Eenoo P; De Backer P
Int J Sports Med; 1998 May; 19(4):287-90. PubMed ID: 9657371
[TBL] [Abstract][Full Text] [Related]
19. [An evaluation method for the determination and monitoring of urinary HCG].
Kalenga MK; de Hertogh R; Loumaye E; Vankrieken L; Thomas K
Rev Fr Gynecol Obstet; 1990 Mar; 85(3):167-73. PubMed ID: 2333459
[TBL] [Abstract][Full Text] [Related]
20. Immuno-MS based targeted proteomics: highly specific, sensitive, and reproducible human chorionic gonadotropin determination for clinical diagnostics and doping analysis.
Lund H; Løvsletten K; Paus E; Halvorsen TG; Reubsaet L
Anal Chem; 2012 Sep; 84(18):7926-32. PubMed ID: 22894612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
